Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators. Mauri L, et al. Among authors: dauerman hl. N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16. N Engl J Med. 2014. PMID: 25399658 Free PMC article. Clinical Trial.
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.
Mauri L, Kirtane AJ, Windecker S, Yeh RW, Dauerman HL, Price MJ, Christen T, Allocco DJ, Meredith IT, Kereiakes DJ. Mauri L, et al. Among authors: dauerman hl. Am Heart J. 2018 Nov;205:110-117. doi: 10.1016/j.ahj.2018.08.004. Epub 2018 Aug 17. Am Heart J. 2018. PMID: 30218844 Clinical Trial.
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Rinaldi MJ, et al. Among authors: dauerman hl. Am Heart J. 2008 Apr;155(4):654-60. doi: 10.1016/j.ahj.2007.11.028. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371472
Platelet-mediated thrombosis and drug-eluting stents.
Granada JF, Price MJ, French PA, Steinhubl SR, Cutlip DE, Becker RC, Smyth SS, Dauerman HL. Granada JF, et al. Among authors: dauerman hl. Circ Cardiovasc Interv. 2011 Dec 1;4(6):629-37. doi: 10.1161/CIRCINTERVENTIONS.111.964635. Circ Cardiovasc Interv. 2011. PMID: 22186107 Review. No abstract available.
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.
Kirtane AJ, Stoler R, Feldman R, Neumann FJ, Boutis L, Tahirkheli N, Toelg R, Othman I, Stein B, Choi JW, Windecker S, Yeh RW, Dauerman HL, Price MJ, Underwood P, Allocco D, Meredith I, Kereiakes DJ. Kirtane AJ, et al. Among authors: dauerman hl. Circ Cardiovasc Interv. 2021 Mar;14(3):e010144. doi: 10.1161/CIRCINTERVENTIONS.120.010144. Epub 2021 Mar 1. Circ Cardiovasc Interv. 2021. PMID: 33641374
Vascular closure devices: the second decade.
Dauerman HL, Applegate RJ, Cohen DJ. Dauerman HL, et al. J Am Coll Cardiol. 2007 Oct 23;50(17):1617-26. doi: 10.1016/j.jacc.2007.07.028. J Am Coll Cardiol. 2007. PMID: 17950141 Free article. Review.
Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.
Solomon R, Gordon P, Manoukian SV, Abbott JD, Kereiakes DJ, Jeremias A, Kim M, Dauerman HL; BOSS Trial Investigators. Solomon R, et al. Among authors: dauerman hl. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1519-24. doi: 10.2215/CJN.05370514. Epub 2015 Jul 16. Clin J Am Soc Nephrol. 2015. PMID: 26185263 Free PMC article. Clinical Trial.
190 results